Sonlicromanol not checked

Khondrion BV · KH176

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
5 in total · 2 in the EU

What this is

How it works
How it works isn't classified yet
How it’s given
“Administration of 90 mg sonlicromanol (100 mg sonlicromanol.HCl) twice daily during 52 weeks”In the company’s words, NCT06451757 on ClinicalTrials.gov
Tested for
Mitochondrial Diseases, Maternally Inherited Diabetes and Deafness (MIDD), Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS), Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation
Main trialPhase 3
“The KHENERFIN study aims to determine whether the study medicine, sonlicromanol, is able to reduce symptoms of fatigue and the impact of fatigue on daily life, and whether sonlicromanol is able to improve physical abilities of people like balance control and lower limb skeletal muscle strength in people with mitochondrial disease. In this study, the effects of sonlicromanol are compared against a placebo, a tablet identical in appearance and taste but without the active drug. Participants take either sonlicromanol or placebo twice daily for a treatment duration of 52 weeks. In addition to…”In the company’s words, NCT06451757 on ClinicalTrials.gov
Other names
KH176

Other drugs for Mitochondrial Diseases

All 15 drugs for Mitochondrial Diseases

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Sep 2029 KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Phase 2Completed 24 May 2022 The KHENERGYZE Study
Phase 2Suspended 1 Dec 2025 The KHENERGYC Study
Phase 1Completed Sep 2015 A Dose-escalating Clinical Trial With KH176
Phase 2Authorised not given SON4PEM study: Sonlicromanol in post-COVID: A randomized, double-blind, placebo-controlled, phase II trial
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Sonlicromanol

Following is part of Solo: you see every change to Sonlicromanol the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in